2/24/17

Curemark Announces Further Expansion of Clinical Sites For Its Phase 3 Clinical Trial for Children with Autism

Curemark, LLC announced today that the Blüm Study, a Phase 3 clinical trial to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at three new sites. These new sites are in addition to the 30 clinical sites already enrolling children across the United States….

Read More

9/20/16

Segal Institute for Clinical Research Takes Essential Step to Reduce Duplicate Enrollment In Clinical Trials

Segal Institute for Clinical Research has chosen Verified Clinical Trials (VCT), the global clinical trial database registry utilizing biometric fingerprint technology, to counter attempts at duplicate enrollment in clinical trial research and improve the safety of research volunteers and data quality…

Read More

5/11/16

Mental Health Organizations Work Together to Educate, Support and Encourage People to Take Action against an Illness that affects Millions of People Every Year

People are diagnosed with mental illness every day. Statistics alone would alarm anyone unfamiliar with the condition; a rare occurrence, as mental disorders affect one in four people…

Read More

1/8/16

Segal Institute for Clinical Research Proudly Participates in Phase 3 Efficacy Trial of Long-acting Treatment Opioid Dependence

Segal Institute for Clinical Research has three Principal Investigators currently participating in Braeburn Pharmaceuticals and Camurus’ Phase 3 efficacy Trial of Long-acting Treatment for Opioid …

Read More

1/8/16

Segal Institute Recognized as Top Fundraiser for Namiwalk Broward County

Segal Institute for Clinical Research was recently recognized as the top fundraiser at the annual NAMIWalk Broward County during NAMI Broward County’s Holiday Party, Volunteer Recognition and Walk…

Read More

1/6/16

Dr.Rishi Kakar of Segal Institute for Clinical Research Listed as an Author on Research Paper

Segal Institute for Clinical Research’s Dr. Rishi Kakar helped to author the research paper, “A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from…

Read More